Where to Give an Ozempic Injection: A Comprehensive Guide

Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Subcutaneous semaglutide injection technique directly affects medication absorption and patient tolerability during weight loss treatment. The three primary injection sites—subcutaneous tissue of the abdomen, anterior thigh, and upper arm—each offer distinct advantages for weekly GLP-1 therapy. Understanding proper site selection and rotation strategies helps PlexusDx patients achieve optimal therapeutic outcomes while reducing injection-site irritation and bruising.

Approved Semaglutide Injection Sites for Weekly Dosing

Semaglutide from licensed 503A compounding pharmacies is administered via subcutaneous injection in three FDA-labeled regions: the abdomen, thigh, and upper arm. The abdominal area provides the largest injection surface and offers consistent absorption rates when injections are placed at least one inch away from the navel. Thigh injections work well for self-administration because patients can easily visualize and access the anterior (front) thigh area without assistance.

The upper arm injection site suits patients with limited abdominal or thigh access and provides reliable subcutaneous depth when targeting the outer surface between shoulder and elbow. Each location contains adequate subcutaneous tissue layers—the fatty tissue between skin and muscle—necessary for proper GLP-1 drug depot formation. Rotating between all three sites across different weeks prevents lipodystrophy (fat pad damage) and ensures consistent medication bioavailability throughout your treatment journey.

Proper Injection Technique and Site Rotation Strategy

PlexusDx recommends selecting a new injection site for each weekly dose rather than using the same location repeatedly, which can cause hardened tissue buildup and reduce absorption. Within the abdominal area, space injections at least one inch apart across the full width of your lower and upper belly region—avoid injecting directly over the belly button or within two inches of any scar tissue. For thigh injections, divide each leg into quadrants and alternate systematically: upper outer thigh, middle outer thigh, lower outer thigh, then switch to the opposite leg each month.

Before injecting, clean the skin with an alcohol swab and let it air-dry completely for fifteen to twenty seconds to reduce infection risk and discomfort. Pinch a small fold of skin with your non-dominant hand, insert the needle at a forty-five to ninety-degree angle depending on your body composition, and inject slowly over five to ten seconds. After withdrawing the needle, release the skin fold and apply gentle pressure with a clean cotton ball—do not rub the injection site, as this can increase local irritation and alter absorption timing.

Avoiding Injection Site Complications and Pain Management

Never inject into areas with active bruising, hardened tissue, scars, moles, or skin conditions like eczema or psoriasis, as these compromise drug delivery and increase discomfort. Injecting into cold skin causes vasoconstriction and slower absorption, so allow injected areas to reach room temperature five minutes before administration. Some patients experience minor injection-site reactions—redness, warmth, or slight swelling—that typically resolve within forty-eight hours; applying a cold compress immediately after injection can minimize these responses.

If bruising or lipohypertrophy (thickened fat deposits) develops at a site, allow that location to rest for at least two to three weeks before reusing it. Using a new needle for each injection, keeping needles sterile in their original packaging, and never reusing sharps reduces infection risk significantly. Patients with needle anxiety benefit from using the smallest gauge needles available (31 or 32 gauge) and taking slow, deep breaths during the injection process to support relaxation and reduce muscle tension.

When to Seek Medical Support for Injection Site Issues

Contact your PlexusDx provider immediately if you develop signs of infection—including increased warmth, spreading redness, pus, or fever—or if injection-site swelling persists beyond seventy-two hours. Severe pain during injection may indicate needle placement into muscle rather than subcutaneous tissue, which requires technique adjustment or provider guidance for future doses. Large bruises, significant hardening, or dimpling at injection sites warrant professional evaluation to assess for lipodystrophy or other complications requiring site modification.

PlexusDx patients starting compounded semaglutide injections at $189/mo (or $149/mo on the 6-month plan) receive comprehensive injection training materials and access to provider support for technique refinement. If you experience persistent discomfort or skin reactions despite proper technique, your provider may recommend alternative GLP-1 formulations such as oral semaglutide or microdose protocols. Regular communication with your PlexusDx care team ensures injection-site safety and optimizes your weight loss medication experience throughout your treatment course.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the correct angle for inserting a semaglutide injection needle?

Insert the needle at a forty-five to ninety-degree angle into the pinched skin fold, with the angle depending on your subcutaneous tissue thickness. Thinner patients may use a steeper angle, while those with more abdominal fat benefit from a forty-five-degree approach. Your PlexusDx provider will guide you on the best angle during your injection training.

Can I use the same injection site every week?

No—rotating injection sites is essential to prevent lipodystrophy and ensure consistent drug absorption. PlexusDx recommends moving to a new location with each weekly dose across your abdomen, thighs, and upper arms to maintain treatment effectiveness and reduce local tissue damage.

How much does compounded semaglutide injection cost at PlexusDx?

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan from licensed 503A compounding pharmacies, with no insurance required and HSA/FSA eligibility available. Your dose may need to go up. Your price won't.

What should I do if I experience bruising after a semaglutide injection?

Minor bruising is common and typically resolves within one to two weeks. Apply ice immediately after injection to reduce swelling, avoid rubbing the site, and skip that injection location for two to three weeks. Persistent or severe bruising warrants contact with your PlexusDx provider to assess technique and prevent complications.

How does genetic testing help optimize my semaglutide injection therapy?

No — the Precision Peptide Genetic Test does not predict your response to GLP-Squared or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Injection Ozempic
• Injection Sites For Ozempic
• Ozempic Injection Sites
• Ozempic Injection

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.